Chronic kidney disease affects virtually every organ system in the body, not just the kidneys. As kidney function declines, the buildup of waste products, the loss of hormonal regulation, and the disruption of fluid and mineral balance create a cascade of complications that range from cardiovascular disease and bone disorders to nerve damage, immune suppression, and mental health struggles. Understanding which complications tend to emerge and how they connect to one another is useful for anyone living with CKD or caring for someone who is.
Cardiovascular Disease and Vascular Calcification
Heart and blood vessel disease is the leading cause of death among people with CKD, and it develops through pathways that go well beyond the usual risk factors like high cholesterol. One of the most distinctive is vascular calcification, where calcium and phosphorus literally deposit in artery walls and heart valves. This stiffens blood vessels, widens pulse pressure, and destabilizes plaques that can trigger heart attacks and strokes.1PubMed. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies The process looks surprisingly similar to how bone forms, and it is driven by elevated phosphorus, calcium-phosphorus imbalance, uremic toxins, chronic inflammation, and oxidative stress.2PubMed Central. Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall
CKD patients face a dramatically elevated risk of ischemic heart disease because of what amounts to premature aging of the cardiovascular system. Calcification does not just clog arteries in the conventional sense; it can stiffen the aorta, cause aortic valve stenosis, and make plaques more prone to rupture.3PubMed Central. Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease This means that even people with CKD who have normal cholesterol levels can develop serious heart problems, which is one reason CKD patients are often undertreated for cardiovascular risk: their disease doesn’t follow the usual pattern.
High Blood Pressure and Fluid Overload
Hypertension and CKD feed off each other. Damaged kidneys retain sodium and water, expanding blood volume. In early CKD, the main driver is overactivation of the renin-angiotensin system, the hormonal circuit that regulates blood pressure. In more advanced stages, sheer volume overload takes over as the dominant mechanism.4PubMed Central. The roles of sodium and volume overload on hypertension in chronic kidney disease The resulting high blood pressure accelerates further kidney damage, creating a cycle that is difficult to break without aggressive sodium restriction and, often, multiple blood pressure medications.
Fluid overload also shows up as swelling in the ankles, shortness of breath, and sometimes pulmonary edema, where fluid accumulates in the lungs. These symptoms tend to worsen as kidney function drops below about a third of normal capacity and the kidneys simply cannot keep up with daily fluid intake.
Bone and Mineral Disorders
The kidneys play a central role in keeping calcium, phosphorus, vitamin D, and parathyroid hormone in balance. When they fail, every part of that system goes haywire. Phosphorus builds up because the kidneys cannot excrete it. Vitamin D activation drops because the kidneys are where the final activation step happens. Calcium levels fall in response. The parathyroid glands then ramp up production of parathyroid hormone to compensate, a condition called secondary hyperparathyroidism.5PubMed Central. Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease
The downstream effects are serious. Bone turnover becomes chaotic, with some patients developing bones that are too soft and others developing bones that are too hard and brittle. Mineralization is impaired, making it harder for calcium and phosphorus to enter bone where they belong, and instead they end up in soft tissues and blood vessels.6PubMed. Mineral bone disorders in chronic kidney disease This overlap between bone disease and vascular calcification is one of the cruelest ironies of CKD: the calcium that should be strengthening your skeleton is instead hardening your arteries. Vitamin D supplementation is a cornerstone of treatment, but managing this balance is tricky, because correcting one abnormality can worsen another.
Anemia
Most people with advanced CKD develop anemia, and it is not the simple iron-deficiency kind that a supplement can fix. The kidneys produce erythropoietin, the hormone that tells bone marrow to make red blood cells. As kidney tissue is lost, erythropoietin production falls, and red blood cell counts drop. On top of that, CKD raises levels of a protein called hepcidin, which blocks iron absorption in the gut and locks iron inside immune cells so the bone marrow cannot use it.7PubMed Central. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease
The result is a double hit: not enough erythropoietin to drive red blood cell production, and not enough usable iron to build them even when erythropoietin-stimulating drugs are given. This hepcidin-driven iron trapping also explains why many CKD patients respond poorly to injectable erythropoietin, a frustrating clinical problem. Symptoms of CKD anemia include persistent fatigue, exercise intolerance, difficulty concentrating, and cold intolerance.
Metabolic Acidosis and Muscle Wasting
Healthy kidneys excrete acid generated by normal metabolism. When they cannot keep up, acid accumulates in the blood, a state called metabolic acidosis. This is far from a minor lab abnormality. Excess acid eats into bone, triggering calcium loss and reduced bone mineral density. It also breaks down muscle protein while simultaneously impairing new protein synthesis, leading to progressive muscle wasting.8Advances in Chronic Kidney Disease. Mechanisms of Metabolic Acidosis-Induced Skeletal Muscle Dysfunction in Chronic Kidney Disease
Population-level data backs this up: people with lower bicarbonate levels tend to walk more slowly, have weaker leg muscles, and develop functional limitations sooner.9PubMed Central. Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment – Section: Consequences of Metabolic Acidosis in CKD The good news is that correcting acidosis with oral bicarbonate or similar base supplements can slow muscle wasting, improve bone health, restore insulin sensitivity, and even slow the progression of CKD itself.10PubMed. Adverse Effects of the Metabolic Acidosis of Chronic Kidney Disease It is one of the more treatable complications, yet it often goes under-recognized.
Hyperkalemia
Potassium is normally excreted by the kidneys, and when that process fails, blood potassium levels rise. This may sound like an obscure lab finding, but high potassium can cause dangerous heart rhythm problems, including sudden cardiac arrest. In CKD, the kidneys’ declining ability to dump potassium is compounded by common medications like ACE inhibitors and potassium-sparing diuretics, which raise potassium further.11PubMed Central. Hyperkalemia in Chronic Kidney Disease: Links, Risks and Management
Managing hyperkalemia is a constant balancing act. Dietary potassium restriction is the first step, which means limiting foods like bananas, oranges, potatoes, and tomatoes. But strict potassium restriction also means cutting back on fruits, vegetables, and other high-fiber foods that are generally good for health, which creates downstream problems for gut health, as discussed below. Newer potassium-binding medications have made this balancing act somewhat easier, but the tension between heart safety and overall nutrition remains a daily reality for many CKD patients.
Gut Problems and the Microbiome
CKD changes the gut in ways that feed back into nearly every other complication. Urea from the bloodstream floods into the intestines, where bacteria convert it into ammonia and other irritants. This damages the gut lining, breaking down the tight junctions between cells and creating what researchers call a “leaky gut.”12PubMed Central. The Gut as a Source of Inflammation in Chronic Kidney Disease Bacterial fragments and toxins then cross into the bloodstream, stoking the chronic inflammation that drives cardiovascular disease, anemia, and further kidney damage.
Making matters worse, the dietary restrictions imposed to manage potassium and phosphorus inadvertently strip the diet of plant fiber and fermented foods that beneficial gut bacteria need. This shifts the microbiome toward species that produce uremic toxins like indoxyl sulfate and p-cresyl sulfate.13PubMed. The Leaky Gut and Altered Microbiome in Chronic Kidney Disease So the dietary advice meant to protect the heart from hyperkalemia may simultaneously damage the gut, increase systemic inflammation, and worsen CKD progression. Researchers are actively looking at whether targeted fiber supplements or pre-selected probiotics can break this cycle without raising potassium levels.
Skin Itching and Uremic Toxins
Persistent, maddening itchiness is one of the most common quality-of-life complaints among people with advanced CKD, yet it is often dismissed or underinvestigated. The itch does not correlate well with how much kidney function someone has lost. Instead, it appears to be driven by the accumulation of specific protein-bound uremic toxins, particularly p-cresyl sulfate.14Dermatology. Increased Levels of Total p-Cresylsulfate Are Associated with Pruritus in Patients with Chronic Kidney Disease These toxins are poorly cleared by standard dialysis because they are bound to proteins in the blood, which is why even patients on regular dialysis can still suffer from severe itching.
Studies of dialysis patients have confirmed that those with higher levels of protein-bound uremic toxins are significantly more likely to report pruritus.15Clinical Kidney Journal. Pruritus and protein-bound uremic toxins in patients undergoing hemodialysis: a cross-sectional study – Section: RESULTS The itching can be severe enough to disrupt sleep, worsen depression, and cause skin damage from constant scratching. Newer therapies targeting the itch pathway directly, rather than just trying to remove toxins, have begun to show promise.
Neurological Effects
The brain and peripheral nerves are both vulnerable to CKD. Uremic encephalopathy, a broad term for the brain dysfunction that comes with poor kidney function, can range from subtle concentration problems and mental fog to confusion, seizures, and coma in severe cases. The syndrome is driven by retained uremic solutes, electrolyte shifts, acid-base disturbances, changes in the blood-brain barrier, and inflammation.16PubMed. Uremic encephalopathy
Peripheral neuropathy, particularly in the legs and feet, is another common problem in advanced CKD. Patients may experience numbness, tingling, burning pain, or restless legs. The mechanism involves accumulation of uremic toxins and oxidative stress damaging nerve fibers.17MEDICUS. The Role of Serum Potassium in Uremic Peripheral Neuropathy: A comparative study between CKD stage 3-4 and stage 5 Restless legs syndrome, which overlaps with peripheral neuropathy, is a frequent source of sleep disruption and is notably more common in CKD than in the general population.
Immune Suppression and Infection Risk
CKD weakens both arms of the immune system. The innate immune response, your first-line defense, becomes sluggish, and the adaptive immune response, which remembers and targets specific infections, also falters. This leaves patients more vulnerable to bacterial, viral, and fungal infections.18PubMed. Immune Dysfunction and Risk of Infection in Chronic Kidney Disease The practical consequences are wide-ranging: CKD patients have higher rates of pneumonia, urinary tract infections, and bloodstream infections, and they respond less robustly to vaccines, including flu and hepatitis B shots.
Multiple factors pile on to increase infection risk: the uremic environment itself, advanced age that often accompanies CKD, coexisting conditions like diabetes, immunosuppressive medications used after transplant, and the dialysis procedure when applicable.19PubMed Central. Epidemiology of acute infections among patients with chronic kidney disease For dialysis patients specifically, the vascular access site is a direct entry point for bacteria. This is why access-site infections remain one of the most common reasons CKD patients are hospitalized.
Nutritional Wasting
A significant proportion of people with advanced CKD develop a wasting syndrome that goes beyond simple malnutrition. While poor appetite and dietary restrictions contribute, the full picture involves uremia-driven increases in energy expenditure, persistent low-grade inflammation, metabolic acidosis, and hormonal disruptions that tip the body into a state of accelerated breakdown of muscle and fat stores.20Journal of Renal Nutrition. Etiology of Protein-Energy Wasting in Chronic Kidney Disease: A Consensus Statement from the International Society of Renal Nutrition and Metabolism (ISRNM) In other words, CKD patients are not just eating too little; their bodies are burning through fuel at an abnormally high rate while simultaneously tearing down tissue.
This wasting is a strong predictor of poor outcomes. It overlaps with the muscle loss driven by metabolic acidosis, and it is worsened by the dietary restrictions needed to control potassium, phosphorus, and sodium. Getting enough protein without overloading the kidneys with waste products is a tightrope walk that typically requires input from a renal dietitian.
Mental Health and Sleep
Depression, anxiety, and sleep problems are pervasive among CKD patients, and they are not just reactions to having a chronic illness. The biological burden of uremia, inflammation, and anemia all contribute to mood and cognitive changes. In studies of patients on dialysis, roughly half show symptoms of anxiety or depression, and over 70% report significant sleep disturbances.21PubMed Central. Correlation analysis of anxiety, depression, and sleep quality in end-stage renal disease patients undergoing maintenance hemodialysis – Section: Results
Pain compounds the problem. About two-thirds of CKD patients report chronic pain, and pain is closely tied to poor sleep, depression, and reduced life satisfaction.22PubMed. Pain, sleep disturbance, and quality of life in patients with chronic kidney disease – Section: RESULTS Yet mental health screening in nephrology clinics remains inconsistent. Addressing depression and sleep problems is not just about comfort; untreated depression is associated with worse treatment adherence, more hospitalizations, and higher mortality in CKD.
Drug Dosing Becomes Unpredictable
A less visible but clinically critical complication of CKD is what it does to the way your body handles medications. When kidney function drops, drug clearance slows down, meaning medications stay in the body longer and can accumulate to toxic levels. But CKD also changes the volume of distribution for many drugs due to fluid retention and altered protein binding, so the relationship between dose and blood level becomes harder to predict.23PubMed Central. Clinical Pharmacokinetics in Kidney Disease: Application to Rational Design of Dosing Regimens
This matters because CKD patients take many medications, often a dozen or more, and several of them are cleared primarily by the kidneys. Antibiotics, blood pressure drugs, pain medications, and diabetes drugs all may need dose adjustments. Getting this wrong can cause serious side effects or, conversely, therapeutic failure if the dose is cut too aggressively.24PubMed Central. Clinical Pharmacokinetics in Kidney Disease: Fundamental Principles This is especially important for older adults and children with CKD, whose drug metabolism is already different from the standard adult.25PubMed Central. Pharmacokinetics in children with chronic kidney disease
Uric Acid and Gout
As kidney function declines, the ability to excrete uric acid drops, and blood levels rise. Elevated uric acid can trigger gout, but its effects in CKD may go beyond painful joints. Research suggests that high uric acid activates the renin-angiotensin system, inhibits nitric oxide production in blood vessels, and stimulates oxidative stress inside cells, all of which can accelerate kidney damage further.26PubMed Central. Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy Whether treating elevated uric acid with medication actually slows CKD progression has been debated for years, though some trials have shown a benefit. At minimum, managing uric acid reduces the frequency of painful gout flares, which is reason enough for most patients.
Complications Unique to Long-Term Dialysis
Dialysis addresses some CKD complications but introduces others. One of the more insidious is dialysis-related amyloidosis, caused by the accumulation of a protein called beta-2 microglobulin. Healthy kidneys clear this protein easily, but dialysis membranes remove it poorly. Over years, beta-2 microglobulin forms amyloid fibrils that deposit in joints and bones, particularly around the wrists, shoulders, and hips.27PubMed Central. Beta-2 Microglobulin Amyloidosis: Past, Present, and Future
Carpal tunnel syndrome is one of the hallmark presentations: patients on dialysis for many years develop wrist pain, numbness, and grip weakness as amyloid deposits compress the median nerve.28PubMed. Beta2-microglobulin and amyloidosis Destructive joint disease and bone cysts can also develop. Amyloid deposits have been found in the bones near joint spaces and in the tissue lining the joints, and the condition is a significant source of long-term morbidity for people who spend years on dialysis.29Journal of the American Society of Nephrology. Beta 2-microglobulin amyloidosis in chronic dialysis patients Higher-flux dialysis membranes clear more beta-2 microglobulin and have reduced the incidence somewhat, but the problem has not disappeared.
Sexual and Reproductive Dysfunction
Sexual problems are common in CKD but rarely discussed in clinic visits. In women, hormonal disruption can cause irregular periods, loss of menstruation, reduced lubrication, and difficulty conceiving.30PubMed Central. Sexual and gonadal dysfunction in chronic kidney disease: Pathophysiology Men frequently experience erectile dysfunction and reduced testosterone. These problems are driven partly by uremia itself and partly by the hormonal chaos that advanced CKD creates, including elevated prolactin, disrupted gonadotropin signaling, and, in some cases, zinc deficiency. The psychological burden of CKD and the side effects of common medications add another layer. Fertility counseling and targeted hormonal treatment can help but are underutilized.
CKD Progression and Self-Reinforcing Damage
Perhaps the most important complication of CKD is that it accelerates itself. Once kidney injury from any cause, be it diabetes, hypertension, or glomerulonephritis, crosses a certain threshold, the remaining kidney tissue becomes overworked and inflamed. Injured tubular cells activate surrounding tissue elements and attract inflammatory cells, leading to scarring of the kidney’s internal architecture.31PubMed Central. Tubulointerstitial injury and the progression of chronic kidney disease This fibrosis replaces functioning tissue and further reduces filtration capacity, which overloads the remaining tissue even more.
This self-reinforcing loop is why CKD often progresses even after the original cause has been treated. It also explains why blood pressure control, acidosis correction, and proteinuria reduction are so heavily emphasized: each one dampens a driver of this progression cycle. Slowing CKD’s decline by even a few years can mean the difference between lifelong medication management and needing dialysis or a transplant.
Growth and Development in Children
When CKD affects children, the complications list gains an additional and distressing dimension: stunted growth. Growth retardation and reduced final adult height are common in pediatric CKD and result from a combination of growth hormone resistance, vitamin D deficiency, elevated parathyroid hormone, poor nutrition, and the side effects of medications like corticosteroids.32Nephrology Dialysis Transplantation. The consequences of chronic kidney disease on bone metabolism and growth in children Bone disease in children takes a particularly severe form because the skeleton is still developing, and disrupted mineralization during growth leads to deformities that may be difficult to correct later. Early intervention with growth hormone therapy and aggressive management of mineral bone disorder can improve outcomes, but timing is critical.
Eye Problems
The eyes are affected by CKD more often than many patients realize. Hypertensive retinopathy, where chronic high blood pressure damages the small vessels of the retina, is common. Diabetic retinopathy overlaps heavily, since diabetes is the leading cause of CKD in most countries. Beyond these, CKD-specific mineral imbalances can cause calcium deposits in the cornea and conjunctiva, and patients on dialysis may develop dry eye and other surface abnormalities. Patients with kidney disease are at higher risk of developing ocular complications either as a direct consequence of renal disease or as a side effect of its treatment.33PubMed Central. Ocular manifestations in renal diseases Regular eye exams are recommended but, like mental health screening, often fall through the cracks in the focus on managing kidney numbers and cardiovascular risk.